Shearman & Sterling Partner Emma Maconick (Menlo Park-IP Transactions) discusses ways companies can mitigate IP-related disputes arising from entities collaborating on COVID-19 vaccines and treatments in Bloomberg Law.

Read “Virus Collaborations Could Create Messy Patent Questions.”